Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00575952
Recruitment Status : Completed
First Posted : December 18, 2007
Last Update Posted : August 24, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Gynecologic Oncology Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 16, 2016
  Study Completion Date : July 16, 2016